Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 109 entries
Sorted by: Best Match Show Resources per page
Skin Autofluorescence in Young Adult Offspring of Women with Type 1 Diabetes: A Cross-Sectional Case-Control Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Korpijaakko C, Wasenius N, Teramo K, Klemetti MM, Kautiainen H, Eriksson JG, Laine MK.
PMID: 33484434
Diabetes Ther. 2021 Mar;12(3):669-677. doi: 10.1007/s13300-021-01001-5. Epub 2021 Jan 23.

INTRODUCTION: Offspring born to women with type 1 diabetes pregnancies have an elevated risk for early-onset obesity and type 2 diabetes compared with offspring born to women without diabetes. Skin autofluorescence (SAF) is a marker of accumulated advanced glycation...

Cite
Korpijaakko C, Wasenius N, Teramo K, et al. Skin Autofluorescence in Young Adult Offspring of Women with Type 1 Diabetes: A Cross-Sectional Case-Control Study. Diabetes Ther. 2021;12(3):669-677doi: 10.1007/s13300-021-01001-5.
Korpijaakko, C., Wasenius, N., Teramo, K., Klemetti, M. M., Kautiainen, H., Eriksson, J. G., & Laine, M. K. (2021). Skin Autofluorescence in Young Adult Offspring of Women with Type 1 Diabetes: A Cross-Sectional Case-Control Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 12(3), 669-677. https://doi.org/10.1007/s13300-021-01001-5
Korpijaakko, Cedric, et al. "Skin Autofluorescence in Young Adult Offspring of Women with Type 1 Diabetes: A Cross-Sectional Case-Control Study." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 12,3 (2021): 669-677. doi: https://doi.org/10.1007/s13300-021-01001-5
Korpijaakko C, Wasenius N, Teramo K, Klemetti MM, Kautiainen H, Eriksson JG, Laine MK. Skin Autofluorescence in Young Adult Offspring of Women with Type 1 Diabetes: A Cross-Sectional Case-Control Study. Diabetes Ther. 2021 Mar;12(3):669-677. doi: 10.1007/s13300-021-01001-5. Epub 2021 Jan 23. PMID: 33484434; PMCID: PMC7947119.
Copy Download .nbib Format: NLM
First trimester glycosylated hemoglobin for gestational diabetes mellitus screening.

Taiwanese journal of obstetrics & gynecology

Çetin C, Güngör ND, Yavuz M.
PMID: 34507669
Taiwan J Obstet Gynecol. 2021 Sep;60(5):899-902. doi: 10.1016/j.tjog.2021.08.002.

OBJECTIVE: Our aim in this study is to evaluate the efficacy of HbA1c in screening for GDM during the first trimester of pregnancy.MATERIALS AND METHODS: In this retrospective cohort study, we evaluated the first trimester HbA1c (ft-HbA1c) levels of...

Cite
Çetin C, Güngör ND, Yavuz M. First trimester glycosylated hemoglobin for gestational diabetes mellitus screening. Taiwan J Obstet Gynecol. 2021;60(5):899-902doi: 10.1016/j.tjog.2021.08.002.
Çetin, C., Güngör, N. D., & Yavuz, M. (2021). First trimester glycosylated hemoglobin for gestational diabetes mellitus screening. Taiwanese journal of obstetrics & gynecology, 60(5), 899-902. https://doi.org/10.1016/j.tjog.2021.08.002
Çetin, Cihan, et al. "First trimester glycosylated hemoglobin for gestational diabetes mellitus screening." Taiwanese journal of obstetrics & gynecology vol. 60,5 (2021): 899-902. doi: https://doi.org/10.1016/j.tjog.2021.08.002
Çetin C, Güngör ND, Yavuz M. First trimester glycosylated hemoglobin for gestational diabetes mellitus screening. Taiwan J Obstet Gynecol. 2021 Sep;60(5):899-902. doi: 10.1016/j.tjog.2021.08.002. PMID: 34507669.
Copy Download .nbib Format: NLM
Association of physical activity and sedentary behavior with type 2 diabetes and glycemic traits: a two-sample Mendelian randomization study.

BMJ open diabetes research & care

Meisinger C, Linseisen J, Leitzmann M, Baurecht H, Baumeister SE.
PMID: 33293297
BMJ Open Diabetes Res Care. 2020 Dec;8(2). doi: 10.1136/bmjdrc-2020-001896.

INTRODUCTION: Observational studies suggest that physical activity lowers and sedentary behavior increases the risk of type 2 diabetes. Despite of some supportive trial data for physical activity, it is largely unresolved whether these relations are causal or due to...

Cite
Meisinger C, Linseisen J, Leitzmann M, et al. Association of physical activity and sedentary behavior with type 2 diabetes and glycemic traits: a two-sample Mendelian randomization study. BMJ Open Diabetes Res Care. 2020;8(2)doi: 10.1136/bmjdrc-2020-001896.
Meisinger, C., Linseisen, J., Leitzmann, M., Baurecht, H., & Baumeister, S. E. (2020). Association of physical activity and sedentary behavior with type 2 diabetes and glycemic traits: a two-sample Mendelian randomization study. BMJ open diabetes research & care, 8(2), . https://doi.org/10.1136/bmjdrc-2020-001896
Meisinger, Christa, et al. "Association of physical activity and sedentary behavior with type 2 diabetes and glycemic traits: a two-sample Mendelian randomization study." BMJ open diabetes research & care vol. 8,2 (2020). doi: https://doi.org/10.1136/bmjdrc-2020-001896
Meisinger C, Linseisen J, Leitzmann M, Baurecht H, Baumeister SE. Association of physical activity and sedentary behavior with type 2 diabetes and glycemic traits: a two-sample Mendelian randomization study. BMJ Open Diabetes Res Care. 2020 Dec;8(2). doi: 10.1136/bmjdrc-2020-001896. PMID: 33293297; PMCID: PMC7725078.
Copy Download .nbib Format: NLM
Relationships between severity of steatosis with glycemic control and carotid intima-media thickness among diabetic patients with ischemic heart disease.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Omar N, Koshy M, Hanafiah M, Hatta SFWM, Shah FZM, Johari B, Zamhuri I, Kasim SS, Rahman TA, Ghani RA.
PMID: 33088301
J Res Med Sci. 2020 Jun 30;25:64. doi: 10.4103/jrms.JRMS_560_17. eCollection 2020.

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) has become one of the major diseases plaguing worldwide. Several studies reported its association with ischemic heart disease (IHD). This study aims to determine the relationships between severity of steatosis with glycemic control...

Cite
Omar N, Koshy M, Hanafiah M, et al. Relationships between severity of steatosis with glycemic control and carotid intima-media thickness among diabetic patients with ischemic heart disease. J Res Med Sci. 2020;25:64doi: 10.4103/jrms.JRMS_560_17.
Omar, N., Koshy, M., Hanafiah, M., Hatta, S. F. W. M., Shah, F. Z. M., Johari, B., Zamhuri, I., Kasim, S. S., Rahman, T. A., & Ghani, R. A. (2020). Relationships between severity of steatosis with glycemic control and carotid intima-media thickness among diabetic patients with ischemic heart disease. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2564. https://doi.org/10.4103/jrms.JRMS_560_17
Omar, Nurazam, et al. "Relationships between severity of steatosis with glycemic control and carotid intima-media thickness among diabetic patients with ischemic heart disease." Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 25 (2020): 64. doi: https://doi.org/10.4103/jrms.JRMS_560_17
Omar N, Koshy M, Hanafiah M, Hatta SFWM, Shah FZM, Johari B, Zamhuri I, Kasim SS, Rahman TA, Ghani RA. Relationships between severity of steatosis with glycemic control and carotid intima-media thickness among diabetic patients with ischemic heart disease. J Res Med Sci. 2020 Jun 30;25:64. doi: 10.4103/jrms.JRMS_560_17. eCollection 2020. PMID: 33088301; PMCID: PMC7554426.
Copy Download .nbib Format: NLM
Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus.

Diabetes & metabolism journal

Yoo SJ, Chang SA, Sohn TS, Kwon HS, Lee JM, Moon S, Proot P, Paldánius PM, Yoon KH.
PMID: 33176094
Diabetes Metab J. 2021 Nov;45(6):954-959. doi: 10.4093/dmj.2020.0173. Epub 2020 Nov 12.

We assessed the glycaemic durability with early combination (EC; vildagliptin+metformin [MET], n=22) versus MET monotherapy (n=17), among newly-diagnosed type 2 diabetes mellitus (T2DM) enrolled (between 2012 and 2014) in the VERIFY study from Korea (n=39). Primary endpoint was time...

Cite
Yoo SJ, Chang SA, Sohn TS, et al. Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes Metab J. 2020;45(6):954-959doi: 10.4093/dmj.2020.0173.
Yoo, S. J., Chang, S. A., Sohn, T. S., Kwon, H. S., Lee, J. M., Moon, S., Proot, P., Paldánius, P. M., & Yoon, K. H. (2021). Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes & metabolism journal, 45(6), 954-959. https://doi.org/10.4093/dmj.2020.0173
Yoo, Soon-Jib, et al. "Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus." Diabetes & metabolism journal vol. 45,6 (2021): 954-959. doi: https://doi.org/10.4093/dmj.2020.0173
Yoo SJ, Chang SA, Sohn TS, Kwon HS, Lee JM, Moon S, Proot P, Paldánius PM, Yoon KH. Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes Metab J. 2021 Nov;45(6):954-959. doi: 10.4093/dmj.2020.0173. Epub 2020 Nov 12. PMID: 33176094.
Copy Download .nbib Format: NLM
Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitis.

Journal of biochemical and molecular toxicology

Reisman SA, Ferguson DA, Lee CI, Proksch JW.
PMID: 32410268
J Biochem Mol Toxicol. 2020 May 14;e22526. doi: 10.1002/jbt.22526. Epub 2020 May 14.

Omaveloxolone is a potent activator of Nrf2, a master transcriptional regulator of a multitude of cytoprotective functions, including antioxidative, anti-inflammatory, and mitochondrial bioenergetic effects. Some of the most potent known effects of Nrf2 involve hepatoprotective functions. The purpose of...

Cite
Reisman SA, Ferguson DA, Lee CI, et al. Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitis. J Biochem Mol Toxicol. 2020;e22526doi: 10.1002/jbt.22526.
Reisman, S. A., Ferguson, D. A., Lee, C. I., & Proksch, J. W. (2020). Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitis. Journal of biochemical and molecular toxicology, e22526. https://doi.org/10.1002/jbt.22526
Reisman, Scott A, et al. "Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitis." Journal of biochemical and molecular toxicology vol. (2020): e22526. doi: https://doi.org/10.1002/jbt.22526
Reisman SA, Ferguson DA, Lee CI, Proksch JW. Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitis. J Biochem Mol Toxicol. 2020 May 14;e22526. doi: 10.1002/jbt.22526. Epub 2020 May 14. PMID: 32410268.
Copy Download .nbib Format: NLM
A high-throughput test for diabetes care: An evaluation of the next generation Roche Cobas c 513 hemoglobin A.

Practical laboratory medicine

Gifford JL, Higgins T, Sadrzadeh SMH.
PMID: 31799362
Pract Lab Med. 2019 Nov 09;17:e00147. doi: 10.1016/j.plabm.2019.e00147. eCollection 2019 Nov.

OBJECTIVES: The level of glycated hemoglobin A (HbADESIGN AND METHODS: Performance was assessed with regards to imprecision, accuracy, linearity, method comparison against the Roche Cobas Integra 800 CTS, specimen stability, interference from common hemoglobin variants and hemoglobin F, and...

Cite
Gifford JL, Higgins T, Sadrzadeh SMH. A high-throughput test for diabetes care: An evaluation of the next generation Roche Cobas c 513 hemoglobin A. Pract Lab Med. 2019;17:e00147doi: 10.1016/j.plabm.2019.e00147.
Gifford, J. L., Higgins, T., & Sadrzadeh, S. M. H. (2019). A high-throughput test for diabetes care: An evaluation of the next generation Roche Cobas c 513 hemoglobin A. Practical laboratory medicine, 17e00147. https://doi.org/10.1016/j.plabm.2019.e00147
Gifford, Jessica L, et al. "A high-throughput test for diabetes care: An evaluation of the next generation Roche Cobas c 513 hemoglobin A." Practical laboratory medicine vol. 17 (2019): e00147. doi: https://doi.org/10.1016/j.plabm.2019.e00147
Gifford JL, Higgins T, Sadrzadeh SMH. A high-throughput test for diabetes care: An evaluation of the next generation Roche Cobas c 513 hemoglobin A. Pract Lab Med. 2019 Nov 09;17:e00147. doi: 10.1016/j.plabm.2019.e00147. eCollection 2019 Nov. PMID: 31799362; PMCID: PMC6881683.
Copy Download .nbib Format: NLM
A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center.

Pharmacy practice

Fink RM, Mooney EV, Saseen JJ, Billups SJ.
PMID: 31897259
Pharm Pract (Granada). 2019 Oct-Dec;17(4):1618. doi: 10.18549/PharmPract.2019.4.1618. Epub 2019 Dec 03.

BACKGROUND: Clinical pharmacists have demonstrated their ability to improve patient outcomes over usual care for patients with type 2 diabetes and glycemic levels above goal, though reasons for this are not well defined. Numerous medications exist for the management...

Cite
Fink RM, Mooney EV, Saseen JJ, et al. A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center. Pharm Pract (Granada). 2019;17(4):1618doi: 10.18549/PharmPract.2019.4.1618.
Fink, R. M., Mooney, E. V., Saseen, J. J., & Billups, S. J. (2019). A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center. Pharmacy practice, 17(4), 1618. https://doi.org/10.18549/PharmPract.2019.4.1618
Fink, Rhianna M, et al. "A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center." Pharmacy practice vol. 17,4 (2019): 1618. doi: https://doi.org/10.18549/PharmPract.2019.4.1618
Fink RM, Mooney EV, Saseen JJ, Billups SJ. A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center. Pharm Pract (Granada). 2019 Oct-Dec;17(4):1618. doi: 10.18549/PharmPract.2019.4.1618. Epub 2019 Dec 03. PMID: 31897259; PMCID: PMC6935544.
Copy Download .nbib Format: NLM
Hemoglobin A1c Is a Predictor of New Insulin Dependence After Partial Pancreatectomy: A Multi-Institutional Analysis.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Wiseman JT, Chakedis J, Beal EW, Paredes A, McElhany A, Fang A, Manilchuk A, Ellison C, Van Buren G, Pawlik TM, Schmidt CR, Fisher WE, Dillhoff M.
PMID: 33948858
J Gastrointest Surg. 2021 Dec;25(12):3119-3129. doi: 10.1007/s11605-021-05014-0. Epub 2021 May 04.

BACKGROUND: Pancreatic diseases have long been associated with impaired glucose control. This study sought to identify the incidence of new insulin-dependent diabetes mellitus (IDDM) after pancreatectomy and the predictive accuracy of hemoglobin A1c (HbA1c) or blood glucose.METHODS: Patients who...

Cite
Wiseman JT, Chakedis J, Beal EW, et al. Hemoglobin A1c Is a Predictor of New Insulin Dependence After Partial Pancreatectomy: A Multi-Institutional Analysis. J Gastrointest Surg. 2021;25(12):3119-3129doi: 10.1007/s11605-021-05014-0.
Wiseman, J. T., Chakedis, J., Beal, E. W., Paredes, A., McElhany, A., Fang, A., Manilchuk, A., Ellison, C., Van Buren, G., Pawlik, T. M., Schmidt, C. R., Fisher, W. E., & Dillhoff, M. (2021). Hemoglobin A1c Is a Predictor of New Insulin Dependence After Partial Pancreatectomy: A Multi-Institutional Analysis. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 25(12), 3119-3129. https://doi.org/10.1007/s11605-021-05014-0
Wiseman, Jason T, et al. "Hemoglobin A1c Is a Predictor of New Insulin Dependence After Partial Pancreatectomy: A Multi-Institutional Analysis." Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract vol. 25,12 (2021): 3119-3129. doi: https://doi.org/10.1007/s11605-021-05014-0
Wiseman JT, Chakedis J, Beal EW, Paredes A, McElhany A, Fang A, Manilchuk A, Ellison C, Van Buren G, Pawlik TM, Schmidt CR, Fisher WE, Dillhoff M. Hemoglobin A1c Is a Predictor of New Insulin Dependence After Partial Pancreatectomy: A Multi-Institutional Analysis. J Gastrointest Surg. 2021 Dec;25(12):3119-3129. doi: 10.1007/s11605-021-05014-0. Epub 2021 May 04. PMID: 33948858.
Copy Download .nbib Format: NLM
High-dose Vitamin D Supplementation on type 1 Diabetes Mellitus Patients: is there an Improvement in Glycemic Control?.

Current diabetes reviews

de Melo FTC, Felício KM, de Queiroz NNM, de Rider Brito HA, Neto JFA, Janaú LC, de Souza Neto NJK, Silva ALA, de Lemos MN, de Oliveira MCNI, de Alcântara AL, de Moraes LV, de Souza ÍJA, Said NM, da Silva WM, de Lemos GN, Dos Santos MC, De Souza D Albuquerque Silva L, Motta ARB, de Figueiredo PBB, de Souza ACCB, Piani PPF, Felício JS.
PMID: 33413064
Curr Diabetes Rev. 2021 Jan 05; doi: 10.2174/1573399817666210106102643. Epub 2021 Jan 05.

BACKGROUND: Some authors evaluated the effect of VD on hyperglycemia in T1DM, but the results remain controversial. This study aims to analyze the effects of high-dose VD supplementation on T1DM patients' glycemic levels, maintaining stable doses of insulin.METHODS: Prospective,...

Cite
de Melo FTC, Felício KM, de Queiroz NNM, et al. High-dose Vitamin D Supplementation on type 1 Diabetes Mellitus Patients: is there an Improvement in Glycemic Control?. Curr Diabetes Rev. 2021;doi: 10.2174/1573399817666210106102643.
de Melo, F. T. C., Felício, K. M., de Queiroz, N. N. M., de Rider Brito, H. A., Neto, J. F. A., Janaú, L. C., de Souza Neto, N. J. K., Silva, A. L. A., de Lemos, M. N., de Oliveira, M. C. N. I., de Alcântara, A. L., de Moraes, L. V., de Souza, �. �. J. A., Said, N. M., da Silva, W. M., de Lemos, G. N., Dos Santos, M. C., De Souza D Albuquerque Silva, L., Motta, A. R. B., de Figueiredo, P. B. B., de Souza, A. C. C. B., Piani, P. P. F., & Felício, J. S. (2021). High-dose Vitamin D Supplementation on type 1 Diabetes Mellitus Patients: is there an Improvement in Glycemic Control?. Current diabetes reviews, . https://doi.org/10.2174/1573399817666210106102643
de Melo, Franciane Trindade Cunha, et al. "High-dose Vitamin D Supplementation on type 1 Diabetes Mellitus Patients: is there an Improvement in Glycemic Control?." Current diabetes reviews vol. (2021). doi: https://doi.org/10.2174/1573399817666210106102643
de Melo FTC, Felício KM, de Queiroz NNM, de Rider Brito HA, Neto JFA, Janaú LC, de Souza Neto NJK, Silva ALA, de Lemos MN, de Oliveira MCNI, de Alcântara AL, de Moraes LV, de Souza ÍJA, Said NM, da Silva WM, de Lemos GN, Dos Santos MC, De Souza D Albuquerque Silva L, Motta ARB, de Figueiredo PBB, de Souza ACCB, Piani PPF, Felício JS. High-dose Vitamin D Supplementation on type 1 Diabetes Mellitus Patients: is there an Improvement in Glycemic Control?. Curr Diabetes Rev. 2021 Jan 05; doi: 10.2174/1573399817666210106102643. Epub 2021 Jan 05. PMID: 33413064.
Copy Download .nbib Format: NLM
Association of glycated hemoglobin A.

Cardiovascular diabetology

Sinning C, Makarova N, Völzke H, Schnabel RB, Ojeda F, Dörr M, Felix SB, Koenig W, Peters A, Rathmann W, Schöttker B, Brenner H, Veronesi G, Cesana G, Brambilla P, Palosaari T, Kuulasmaa K, Njølstad I, Mathiesen EB, Wilsgaard T, Blankenberg S, Söderberg S, Ferrario MM, Thorand B.
PMID: 34781939
Cardiovasc Diabetol. 2021 Nov 15;20(1):223. doi: 10.1186/s12933-021-01413-4.

BACKGROUND: Biomarkers may contribute to improved cardiovascular risk estimation. Glycated hemoglobin AMETHODS: Data from six prospective population-based cohort studies across Europe comprising 36,180 participants were analyzed. HbARESULTS: Kaplan-Meier curves showed higher event rates with increasing HbACONCLUSIONS: HbA

Cite
Sinning C, Makarova N, Völzke H, et al. Association of glycated hemoglobin A. Cardiovasc Diabetol. 2021;20(1):223doi: 10.1186/s12933-021-01413-4.
Sinning, C., Makarova, N., Völzke, H., Schnabel, R. B., Ojeda, F., Dörr, M., Felix, S. B., Koenig, W., Peters, A., Rathmann, W., Schöttker, B., Brenner, H., Veronesi, G., Cesana, G., Brambilla, P., Palosaari, T., Kuulasmaa, K., Njølstad, I., Mathiesen, E. B., Wilsgaard, T., Blankenberg, S., Söderberg, S., Ferrario, M. M., & Thorand, B. (2021). Association of glycated hemoglobin A. Cardiovascular diabetology, 20(1), 223. https://doi.org/10.1186/s12933-021-01413-4
Sinning, Christoph, et al. "Association of glycated hemoglobin A." Cardiovascular diabetology vol. 20,1 (2021): 223. doi: https://doi.org/10.1186/s12933-021-01413-4
Sinning C, Makarova N, Völzke H, Schnabel RB, Ojeda F, Dörr M, Felix SB, Koenig W, Peters A, Rathmann W, Schöttker B, Brenner H, Veronesi G, Cesana G, Brambilla P, Palosaari T, Kuulasmaa K, Njølstad I, Mathiesen EB, Wilsgaard T, Blankenberg S, Söderberg S, Ferrario MM, Thorand B. Association of glycated hemoglobin A. Cardiovasc Diabetol. 2021 Nov 15;20(1):223. doi: 10.1186/s12933-021-01413-4. PMID: 34781939; PMCID: PMC8594211.
Copy Download .nbib Format: NLM
J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention.

Cardiovascular diabetology

Choi IJ, Choo EH, Kim HJ, Lim S, Moon D, Lee KY, Hwang BH, Kim CJ, Park MW, Lee JM, Park CS, Kim HY, Yoo KD, Jeon DS, Chung WS, Kim MC, Jeong MH, Ahn Y, Chang K.
PMID: 34911555
Cardiovasc Diabetol. 2021 Dec 15;20(1):234. doi: 10.1186/s12933-021-01428-x.

BACKGROUND: Intensive glycemic control is generally recommended for diabetic patients to reduce complications. However, the role of glycemic control in the mortality in diabetic patients with acute myocardial infarction (AMI) remained unclear.METHODS: We selected diabetic patients who measured HbA1c...

Cite
Choi IJ, Choo EH, Kim HJ, et al. J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2021;20(1):234doi: 10.1186/s12933-021-01428-x.
Choi, I. J., Choo, E. H., Kim, H. J., Lim, S., Moon, D., Lee, K. Y., Hwang, B. H., Kim, C. J., Park, M. W., Lee, J. M., Park, C. S., Kim, H. Y., Yoo, K. D., Jeon, D. S., Chung, W. S., Kim, M. C., Jeong, M. H., Ahn, Y., & Chang, K. (2021). J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention. Cardiovascular diabetology, 20(1), 234. https://doi.org/10.1186/s12933-021-01428-x
Choi, Ik Jun, et al. "J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention." Cardiovascular diabetology vol. 20,1 (2021): 234. doi: https://doi.org/10.1186/s12933-021-01428-x
Choi IJ, Choo EH, Kim HJ, Lim S, Moon D, Lee KY, Hwang BH, Kim CJ, Park MW, Lee JM, Park CS, Kim HY, Yoo KD, Jeon DS, Chung WS, Kim MC, Jeong MH, Ahn Y, Chang K. J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2021 Dec 15;20(1):234. doi: 10.1186/s12933-021-01428-x. PMID: 34911555; PMCID: PMC8675510.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 109 entries